Equipping Cells for Battle
Academic Degree
Programs
(As of December 2017 BOG
Degree Program Inventory)
Baccalaureate 98
Master’s 126
Professional Doctorate 5
Research Doctorate 80
Specialist 7
5
Professional
(Dentistry, Law, Medicine,
Pharmacy, Veterinary Medicine)
Number of
Degrees Awarded
(1905-Summer 2017)
Baccalaureate 360,908
Master’s 111,744
Specialist 3,352
Engineer 88
Ph.D. 24,353
3,066
EDD 1,419
DMD 2,953
JD 19,327
DPH 7,605
DNP 285
SJD 4
AUD 361
DPM 31
DPT
harmful cells to other parts of the body’s tissues,”
ready to attack cancer cells. These soldiers said Morphogenesis President and CEO Michael
have been armed and equipped for a fight Lawman.
through immunotherapy treatments, which
MD 5,760
DVM
Imagine tiny biological soldiers inside the body uses the body’s own immune system to The process of capturing and releasing the
make the attack. However, every soldier is not cells can be compared to finding a needle in a
created the same and cancer can still break haystack and those searching include two UF
through the well-intended and heavily armed student researchers.
front line.
Tampa’s
Morphogenesis
has
technology
that can help strengthen the weakest links
among the ranks of biological soldiers and
the company partnered with the University of
406
Florida (UF) to advance research through a
Professional (Undesignated – Before 1959) = 75 Matching Grants Research Program project.
All Degrees Carlos Rinaldi, Ph.D., UF professor and interim
chair for the chemical engineering department,
541,737
Fall 2017 Enrollment
55,460
(End of drop/add)
was tasked with reproducing previous exper-
iments and finding conditions in which the
technology can effectively capture cells from
biological fluids and release them to keep them
alive for further study. Most capture methods
“Materials research and
biological and biomedical
testing is expensive,”
said Rinaldi. “It’s really
difficult and expensive
work, so The Corridor
funding has really
enabled Morphogenesis
to initiate this project.”
Lawman agrees.
“Without
the
Matching
Grants
Research
kill the cells. Program, we wouldn’t have been able to do
After obtaining often-rare cells from a blood we almost had to put this research away on a
sample of a person with cancer, the new
method could help develop personalized
immunotherapy treatments and “clean the
cancer patient’s blood of cancer,” according
this project,” said Lawman. “As a company,
shelf because of lack of funding, but with The
Corridor we have been able to concentrate on
this and take these developments to clinical
trials this year.”
to Rinaldi.
“With the machine isolating the rare circulating
tumor cells, we can end the spread of these
f l o r i d a H I G H T E C H . c o m | 37